SCIENCE
April 20, 2012 | By Eryn Brown, Los Angeles Times
DNA and RNA molecules are the basis for all life on Earth, but they don't necessarily have to be the basis for all life everywhere, scientists have shown. Researchers at the Medical Research Council in Cambridge, England, demonstrated that six synthetic molecules that are similar to - but not exactly like - DNA and RNA have the potential to exhibit "hallmarks of life" such as storing genetic information, passing it along and undergoing evolution. The man-made molecules are called "XNAs.
HEALTH
April 4, 2012 | By Melissa Healy, Los Angeles Times
Just before noon on a December morning in 1988, a magnitude 6.8 earthquake shook over 40% of the territory of Armenia, centered in the northern city of Spitak. The temblor leveled entire towns and cities, killed an estimated 25,000 Armenians - two-thirds of them children trapped and crushed in their crumbling schools - and hastened the dissolution of the Soviet Union, of which Armenia was then a part. But the Spitak disaster was more than a geopolitical milestone. The earthquake was, in the words of one researcher, a "psychiatric calamity" that has yielded a trove of knowledge aboutpost-traumatic stress disorder.
BUSINESS
March 12, 2012 | By Chad Terhune, Los Angeles Times
Spending on genetic tests has reached $5 billion annually and could top $25 billion within a decade, according to an insurance industry study published Monday. The rise in spending is likely to intensify the debate over genetic testing as policymakers and employers struggle to contain spiraling healthcare costs. The growing availability of genetic and molecular diagnostic tests offers the promise of earlier detection of disease and more personalized treatments that could wring substantial savings from the nation's $2.6 trillion-a-year healthcare tab. But many medical providers and other experts worry that those benefits may be outweighed by indiscriminate use of genetic testing, similar to what has occurred with some spending on popular prescription drugs and expensive imaging tests.
NEWS
March 8, 2012 | By Eryn Brown, Los Angeles Times / for the Booster Shots blog
Patients are holding out hope that someday - soon, they hope - physicians will be able to personalize medical treatment more precisely than they've been able to in the past. For people with cancer, this might mean taking a quick biopsy, studying the genetic profile of a tumor and then tailoring interventions to target the cancer effectively, with as few side effects as possible. But a study published in the New England Journal of Medicine on Wednesday underscores why the vision remains a challenge. Cancer researchers in England showed that individual kidney tumors and their metastases had different mutations in different locations - and that those mutations, in turn, affect the biology of those tumors in varying ways in different locations. “A single tumor-biopsy-specimen reveals a minority of genetic aberrations … that are present in an entire tumor,” wrote Dr. Marco Gerlinger of the Cancer Research UK London Research Institute and co-authors. For example, the scientists found that one region of a renal carcinoma could display gene expression signatures associated with a good prognosis, while signatures in another region of the same tumor could be associated with a poor prognosis.
ENTERTAINMENT
December 31, 2011 | By Scarlet Cheng, Special to the Los Angeles Times
Adrian Saxe is a ceramic artist known for juxtaposing the Historic and the Now with a trippy sense of humor. His latest musings in the show "GRIN — Genetic Robotic Information Nano," at Frank Lloyd Gallery through Jan. 7, incorporate Quick Response (QR) codes, or the square bar codes, into sculpture that emulate antique Chinese vases and scholar's rocks — rocks collected for their unusual and evocative forms. "Made to seduce and then betray, Saxe's elegant vessels present provocative concepts," curator Martha Drexler Lynn wrote for his 1993 retrospective at LACMA, "The Clay Art of Adrian Saxe.
CALIFORNIA | LOCAL
November 16, 2011 | Los Angeles Times staff and wire reports
Har Gobind Khorana, who rose from poverty in rural India to become a giant of modern biology, winning the Nobel Prize in 1968 for work that helped decipher the genetic code and explain how cells make proteins, died Nov. 9 in Concord, Mass. He was 89. Khorana died of natural causes, according to the Massachusetts Institute of Technology, where he was an emeritus professor of biology and chemistry. Described by colleagues as brilliant and humble, Khorana shared the 1968 Nobel Prize for physiology or medicine with two other scientists, Robert W. Holley of Cornell University and Marshall W. Nirenberg of the National Institutes of Health.